NPM1 and acute myeloid leukemia: In the context of this study, a preliminary analysis on nine NPM1-mutant AML patients with MRD-positivity showed an NPM1 mutant ≥ 1 log10 MRD reduction in 62.5% of the patients, with 37.5% of the patients achieving MRD negativity [104].